MMED (Minimed Group) Cash per Share: $1.06 (As of Apr. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MMED Minimed Group Inc MMED
15 GF Score
Price $19.85
! 3 Warning Signs
View Full Analysis

What is Minimed Group Cash per Share?

Minimed Group MMED +1.77% 15 Cash per Share is $1.06 as of Apr. 2026. GuruFocus rates MMED with a GF Score™ of 15/100. The stock has 3 warning signs investors should review.

Cash per Share is calculated as Cash, Cash Equivalents, Marketable Securities divided by Shares Outstanding (EOP). Minimed Group's Cash per Share for the quarter that ended in Apr. 2026 was $1.06.


Minimed Group  (NAS:MMED) Cash per Share Explanation

Cash per Share represents the liquidity of a compant's assets. A high level of Cash per Share suggests that there's enough money on hand for a company to cover any emergencies and that the company has adequate money to reinvest its business or pay dividends to investors. However, if the ratio is too high, it can also suggeust the inefficiency of management for not making a full usage of the cash.


Minimed Group Cash per Share Related Terms


Minimed Group Cash per Share Historical Data

* Premium members only.

The historical data trend for Minimed Group's Cash per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Minimed Group Cash per Share Chart

Minimed Group Annual Data
Trend Apr23 Apr24 Apr25 Apr26
Cash per Share
0.00 0.19 0.04 1.06

Minimed Group Quarterly Data
Apr24 Jan25 Apr25 Oct25 Jan26 Apr26
Cash per Share Get a 7-Day Free Trial 0.00 0.04 1.25 0.04 1.06
MMED
15GF Score
Minimed Group Inc MMED
Cash per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Minimed Group Cash per Share Calculation

This is the ratio of a company's available cash, including easy to liquidate short-term investment, to its total number of shares outstanding. The result indicates the percentage of a company's share price that is available to spend on company's activities, such as strengthening the business, paying down the debt and making dividend payment to shareholders. It's a reliable indicator of a company's financial health.

Minimed Group's Cash per Share for the fiscal year that ended in Apr. 2026 is calculated as:

Minimed Group's Cash per Share for the quarter that ended in Apr. 2026 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Cash per Share →
What does a Cash per Share of $1.06 mean?
Minimed Group (MMED) has a Cash per Share of $1.06 as of Apr. 2026. Cash per share is the per-share value of a company's available cash. View historical data for Minimed Group and its competitors.
Is Minimed Group's Cash per Share too high?
Minimed Group's current Cash per Share is $1.06. Overall, Minimed Group has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Minimed Group's Cash per Share compare to MMSI and NVST?
Minimed Group's Cash per Share of $1.06 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash per Share for a Medical Devices & Instruments company?
A good Cash per Share depends on the Medical Devices & Instruments industry context. However, Cash per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash per Share mean?
A high Cash per Share can signal that a stock is expensive relative to its fundamentals. Cash per share is the per-share value of a company's available cash. View historical data for Minimed Group and its competitors. Minimed Group's current Cash per Share is $1.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Minimed Group stock overvalued right now?
Minimed Group (MMED) has a current Cash per Share of $1.06. The current Cash per Share is $1.06. Minimed Group's overall GF Score™ is 15/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash per Share calculated?
Cash per Share is calculated from a company's financial statements. For Minimed Group (MMED), the current Cash per Share is $1.06 as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Minimed Group Business Description

Other Exchanges B8S:Germany
Address 18000 Devonshire Street, Northridge, CA, USA, 91325
Minimed Group Inc is a medical technology firm that develops, manufactures, and markets products and solutions for diabetes management. It offers automated insulin pumps, continuous glucose monitoring systems and sensors, and smart insulin pens as its main products. The company sells these through direct-to-consumer channels and healthcare providers of various countries. The company's revenues are principally derived from the sale of reusable and single-use products which together comprise AID systems and smart multiple daily injection (MDI) systems for diabetes management to individuals, distributors, healthcare providers, and other institutions globally.
15GF Score

Get the complete analysis for MMED

Cash per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$19.85
Price